Home Speakers

Speakers

  • Oded Rechavi Sagol School of Neuroscience, Tel Aviv University, Israel
  • Maria‑Elena Torres Padilla Helmholtz Zentrum München, Germany
  • Kenneth Zaret University of Pennsylvania, Philadelphia, USA
  • Julie Ahringer CRUK Gurdon Institute, University of Cambridge, UK
  • Cecilia Arraiano Universidade Nova de Lisboa, Portugal
  • Andreas Beyer University of Cologne, Cologne, Germany
  • Petra Hajkova MRC London, UK
  • Kristian Helin Institute of Cancer Research, UK
  • Ian R Henderson University of Cambridge, UK
  • Nicola Iovino Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany
  • Helena Jambor Technischen Universität Dresden, Germany
  • Rob Klose University of Oxford, UK
  • Tineke Lenstra Netherlands Cancer Institute, Amsterdam, The Netherlands
  • Susan Mango University of Basel, Switzerland
  • Celia P. Martinez‑Jimenez Helmholtz Zentrum München, Germany
  • Eric Miska CRUK Gurdon Institute, University of Cambridge, UK
  • J. Andrew Pospisilik Van Andel Research Institute, MI, US
  • Claire Rougeulle Université Paris Cité, CNRS, Epigenetics and Cell Fate, Paris, France
  • Cornelius Schneidert The EMBO Journal
  • Peter Tessarz Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
  • Laszlo Tora IGBMC, Strasbourg, France
  • Michiel Vermeulen Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands

Deadlines

  • Payment of early registration fee
    15 July 2024
  • Recommended date for hotel reservation
    31 August 2024
  • Late abstract submission
    6 September 2024
  • Cancellation of registration without penalty
    31 August 2024

FEBS has twin commitments to high-quality publications and the promotion of molecular biosciences. As a charitable academic organization,
FEBS uses income from the journals to fund its diverse activities, including support for FEBS Advanced Courses.